Tilray Brands, Inc. stock forum

5 days ago

Despite Tilray's current financial challenges, including cash burn and lack of profitability, the recent disclosure by Bryan Lanza regarding potential medical cannabis legalization could significantly benefit the company. Tilray's strong focus on medical cannabis products and its established presence in the market position it well to capitalize on any regulatory changes. The anticipated legalization could open up new revenue streams and improve market sentiment, potentially attracting investors and boosting stock performance. This development underscores Tilray's potential to emerge as a key player in the evolving cannabis industry.

Additionally, Donald Trump's recent promise to support medical cannabis legalization, combined with Bryan Lanza's close connection to him as a senior advisor, further strengthens the likelihood of favorable policy changes. This political backing could provide Tilray with a significant advantage in navigating the regulatory landscape and expanding its market presence.

Check out the new video that just came out on YouTube on Lanza's interview.

6 days ago

people are tax harvesting right now. it will go back to its normal levels in January

7 days ago

…like every other ganja stonk they’ll rs 10:1 when it gets down to ~.30

Dec 11

this will never recover. it's -94% . pure trash

Dec 9

buy buy buy

Nov 21

...loading the truck with 30,000 shrs goal ...here @ 52wk low

Nov 19

Tilray CFO Carl Merton's spouse recently purchased 26,000 shares of at $1.36 per share, signaling confidence in the company's future. Insider buying like this often aligns leadership interests with shareholders and reflects belief in the company's potential. A bullish sign for investors!

Sep 20

if it dips one more time, i'm loading up

Jul 30

is the 6th highest grossing craft beer distributor in the US. #1 in market share of cannabis in Canada and Germany. Institutional investment has been low but I think that tide should be shifting soon... As management seems to have effectively diversified.
Insiders (board members) are buying, directly and indirectly, debt to asset ratio leaves something to be desired but interesting nonetheless. Am I missing something? I'm open to info, especially to the contrary (please offer criticism - without worry of drama. I'm asking for a contradictory analysis - it keeps strategies honest).

Jun 24

broke the trend? see if it sticks...